Telomir Pharmaceuticals, Inc. · Brief

Next report

8 days

Nov 12est.Q3 FY26

Expected move

No implied move.

No reported quarters.

Nov 12 report · est.

Bull2

+42.49%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

2 of 17of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

Bear1

4managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

TELO report session

No linked exposure.

Oct 68-KMaterial agreement: 8-K Item 1.01.Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.